Mark C. Kelley

6.8k citations
56 papers · 4.7k · 2 hit papers · h-index 32

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 1%
    • Cutaneous Melanoma Detection and Management

Papers in

    • Cutaneous Melanoma Detection and Management 12
    • Cancer Immunotherapy and Biomarkers 5
    • Melanoma and MAPK Pathways 9

Mark C. Kelley

54 papers receiving 4.6k citations

Mark C. Kelley's Hit Papers

Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy 2019 · 540 citations
5400+4+8Years since publication200400600

Peers

Mark C. Kelley
Comparison fields: 5 of 119
  • Cancer Research 1.1k
  • Oncology 1.8k
  • Biophysics 312
  • Radiology, Nuclear Medicine and Imaging 954
  • Pathology and Forensic Medicine 743
Replace Abeer M. Shaaban with:
Abeer M. Shaaban United Kingdom
Richard M. Neve United States
Maarit Bärlund Finland
Andrew M. Hanby United Kingdom
Stephen B. Leighton United States
Aurelia Noske Germany
Lu Si China
Regina Gandour‐Edwards United States
Marco Novelli United Kingdom
Thierry Dorval France
Mark C. Kelley relative to Abeer M. Shaaban United Kingdom Abeer M. Shaaban's profile →
Citations per field
00.5×2.9×
Abeer M. Shaaban · 1×
Citations per year

Countries citing papers authored by Mark C. Kelley

Since Specialization
Citations

This map shows the geographic impact of Mark C. Kelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Kelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Kelley more than expected).

Fields of papers citing papers by Mark C. Kelley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Kelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Kelley. The network helps show where Mark C. Kelley may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark C. Kelley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark C. Kelley Line = papers co-authored together Mark C. Kelley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
Hit paper breakdown →
2013715
2
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
Hit paper breakdown →
2019540
3 2000468
4 2006264
5 2011157
6 2015149
7 1999146
8 2010142
9 2014127
10 2005112
11 1997111
12 2004110
13 201397
14 202096
15 201092
16 201689
17 201988
18 200887
19 201482
20 201278

About Mark C. Kelley

Mark C. Kelley is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Pathology and Forensic Medicine, having authored 56 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (12 papers), Breast Cancer Treatment Studies (11 papers), Melanoma and MAPK Pathways (9 papers), MRI in cancer diagnosis (9 papers), Breast Lesions and Carcinomas (7 papers), Advanced MRI Techniques and Applications (6 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.8k citations), Biophysics (312 citations), Radiology, Nuclear Medicine and Imaging (954 citations) and Pathology and Forensic Medicine (743 citations). Mark C. Kelley has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Douglas B. Johnson, Nora Hansen, Edwin C. Glass, Ingrid M. Meszoely, Ingrid A. Mayer, Jeffrey A. Sosman, Armando E. Giuliano, Meghan B. Brennan, Philip I. Haigh and Wei Ye. Their work appears in journals such as Clinical Cancer Research, Annals of Surgical Oncology, Journal of Clinical Oncology, Cancer and Journal of Biomedical Optics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact